American Beacon Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,237
Closed -$464K 21
2018
Q3
$464K Buy
2,237
+428
+24% +$84.3K 3.15% 1
2018
Q2
$334K Buy
1,809
+719
+66% +$127K 3.07% 2
2018
Q1
$186K Hold
1,090
1.97% 13
2017
Q4
$190K Buy
1,090
+442
+68% +$78.2K 2.03% 11
2017
Q3
$121K Hold
648
1.44% 17
2017
Q2
$112K Hold
648
1.43% 19
2017
Q1
$106K Buy
+648
New +$108K 1.39% 18

Other funds holding AMGN

American Beacon Advisors's AMGN Position: Q4 2018 in Review

American Beacon Advisors sold out of Amgen (AMGN) in Q4 2018, closing a stake of 2,237 shares — an estimated $464K sold.

American Beacon Advisors first reported a position in AMGN in Q1 2017 and held it in 7 quarters. The position peaked at $464K in Q3 2018. 1,891 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

  • American Beacon Advisors reported no remaining Amgen position as of Q4 2018 after selling out during the quarter.
  • American Beacon Advisors sold 2,237 Amgen shares in Q4 2018, an estimated $464K.
  • American Beacon Advisors first reported a position in Amgen in Q1 2017 and held it in 7 quarters.
  • American Beacon Advisors's Amgen position peaked at $464K in Q3 2018.
  • 1,891 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on American Beacon Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.